Research published this week describes a promising start to using stem cell therapy for multiple sclerosis. In a small Phase I trial, patients who had stem cells directly injected into their brain appeared to tolerate it well and experienced no serious adverse effects. The treatment may have also stopped or slowed the…
Shady stem cell clinics are still peddling false hope to people dealing with covid-19, new research this week suggests. The study found dozens of clinics selling stem cell treatments for covid-related issues, especially long covid. These therapies often cost thousands of dollars, but there’s no good evidence that they…
